{
  "schema_version": "0.1.0",
  "case_id": "HR-ML005",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML005",
    "display_name": "Judy Garland",
    "aliases": [
      "Frances Ethel Gumm"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1922-06-10",
          "display": "June 10, 1922",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1922",
              "display": "1922",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0011"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1969-06-22",
          "display": "June 22, 1969",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1969",
              "display": "1969",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0011"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML005-SYN",
      "ssn": "000-05-6127",
      "date_of_birth": "1993-06-10",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Margaret Ellsworth-Diaz, MD",
      "fictional_consultant": {
        "name": "Tobias Grünewald, MD",
        "specialty": "Addiction Medicine"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1922-06-10",
        "display": "June 10, 1922",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Frances Ethel Gumm in Grand Rapids, Minnesota.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1935",
        "display": "1935",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Signed by Metro-Goldwyn-Mayer at 13.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1939",
        "display": "1939",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "A national star at 17 in The Wizard of Oz; by then taking stimulant and sleeping pills given to her as a teenage performer.",
      "claim_ids": [
        "CLM-0002",
        "CLM-0003",
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1949",
        "display": "1949",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Hospital stay in Boston; treated for what was publicly called exhaustion.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1950",
        "display": "1950",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Studio contract ended; a suicide attempt was reported publicly; return to the stage in concert.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1954",
        "display": "1954",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "A Star Is Born released; Academy Award nomination.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1955-03",
        "display": "March 1955",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Birth of her third child.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1955-09-24",
        "display": "September 24, 1955",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Television debut on the first Ford Star Jubilee broadcast.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1959",
        "display": "1959",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Hospitalized with acute hepatitis.",
      "claim_ids": [
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1969-06-22",
        "display": "June 22, 1969",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in London at 47; the coroner ruled the death an accidental barbiturate overdose.",
      "claim_ids": [
        "CLM-0013"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Judy Garland was born Frances Ethel Gumm on June 10, 1922, in Grand Rapids, Minnesota, to parents in vaudeville, and first appeared on stage as a small child.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "born in Grand Rapids, Minn., to parents in vaudeville"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0011",
          "relationship": "context",
          "locator": "roster birth year 1922"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She was signed by Metro-Goldwyn-Mayer at 13 and became a national star at 17 in The Wizard of Oz.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her work as a performer from childhood and the studio years in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "at age 13, she was signed"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "a national legend at 17"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "As a teenage studio performer she was given stimulant \"pep pills\" (amphetamines; Benzedrine is named) to suppress her appetite and keep up her energy through long working days, and sleeping pills (barbiturates; Seconal is named) so that she could sleep. She later described being given pills to stay on her feet and then being put to sleep with sleeping pills at the studio hospital.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic sedative-hypnotic and stimulant use disorders and for the teaching point: dependence that began with drugs given to a minor by adults with power over her. Recorded without blame.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "studio pep pills and her account of the studio hospital"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "prescribed pills by MGM studio doctors to control both her weight and her energy levels"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "pep pills (amphetamines) and downers (barbiturates)"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "a regimen of Benzedrine to control her appetite and Seconal"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Accounts differ on who first gave her the pills. A biography by Gerald Clarke reports that her mother gave her pills for energy and sleep in early childhood, before she joined the studio; other accounts attribute the pills to the studio and its doctors.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "Recorded only to show that the account of how her dependence began is contested; the episode relies on the documented fact that the pills were given to her as a minor, not on who began it.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "per Clarke, her mother was the first to provide pills"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "supports",
          "locator": "summarizes Clarke's account of amphetamines in early childhood"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "introduced to pep pills by her mother"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "disputes",
          "locator": "pills prescribed by studio doctors"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "She struggled with dependence on prescribed medicines, stimulants and sleeping pills, for the rest of her life; by her twenties she was already dependent on pills.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for long-term dependence in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "addictions to various medications for the rest of her life"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "already dependent on pills"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "years of addiction to upper and downer prescription pills"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "Suicide attempts were reported publicly, including one in 1950; a biographical encyclopedia describes others in the 1940s and early 1950s.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, without detail. In the modern episode it is a historical risk factor in the structured safety assessment.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "attempted suicide in 1950"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "had attempted suicide"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In her twenties she was treated for what was publicly called exhaustion and spent periods in hospitals and sanitariums, including a stay at Peter Bent Brigham Hospital in Boston in 1949.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, without detail.",
      "source_links": [
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "was treated for mental exhaustion"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Peter Bent Brigham Hospital, 1949"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Her contract with Metro-Goldwyn-Mayer ended in 1950, and she returned to the stage in concert.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "after her MGM firing in 1950"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "released from her MGM contract; return to the stage"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "wildly successful concert comebacks"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She starred in A Star Is Born, released in 1954, and was nominated for the Academy Award for Best Actress.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her film work in the year before the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Oscar nominations for A Star Is Born"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "She gave birth to her third child, a son, in March 1955.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the postpartum timing of the modern episode; the child is not named.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "gave birth prematurely to a healthy son in March"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "On September 24, 1955, she made her television debut on the first Ford Star Jubilee broadcast.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the index visit.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports",
          "locator": "Ford Star Jubilee, which begins tonight with Judy Garland's TV bow"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "In 1959 she was hospitalized with acute hepatitis and liver disease.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode; the episode records no liver disease.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "a bout with acute hepatitis"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0013",
      "statement": "She died in London on June 22, 1969, at 47; the coroner ruled her death an accidental overdose of barbiturates.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, recorded in one plain sentence.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "ruled as accidental, an overdose of barbiturates"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "ruled as an accidental overdose of sleeping pills"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "coroner's report listing an overdose of sleeping pills"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "died in London"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Powers N. Garland, Judy (1922-1969). Women in World History: A Biographical Encyclopedia (Gale)",
      "publisher": "Encyclopedia.com",
      "url": "https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/garland-judy-1922-1969",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Reference encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Milestones, Jun. 27, 1969",
      "publisher": "TIME",
      "url": "https://time.com/archive/6637032/milestones-jun-27-1969",
      "source_type": "other",
      "published": "1969-06-27",
      "accessed": "2026-11-04",
      "rights_note": "Contemporary news-magazine death notice; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "5 Interesting Facts About Judy Garland",
      "publisher": "PBS American Masters (WNET)",
      "url": "https://www.pbs.org/wnet/americanmasters/blog/5-interesting-facts-about-judy-garland",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Public broadcaster biography page; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Haynes S. The True Story Behind Judy, the New Film Based on Judy Garland's Life",
      "publisher": "TIME",
      "url": "https://time.com/5684673/judy-garland-movie-true-story/",
      "source_type": "other",
      "published": "2019-09-26",
      "accessed": "2026-11-04",
      "rights_note": "News-magazine article drawing on Gerald Clarke's biography; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Bertram C. Judy Garland Filmed The Wizard of Oz Under Grueling Conditions",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/actors/judy-garland-pills-diet-wizard-of-oz",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Reference article citing Gerald Clarke and Paul Donnelley; facts used with citation; updated December 2, 2024."
    },
    {
      "source_id": "SRC-0006",
      "title": "Blakemore E. Golden Age Hollywood Had a Dirty Little Secret: Drugs",
      "publisher": "History.com (A&E Television Networks)",
      "url": "https://www.history.com/articles/judy-garland-barbiturates-hollywood-studio-drugs",
      "source_type": "other",
      "published": "2018-03-01",
      "accessed": "2026-11-04",
      "rights_note": "History article; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Bertram C. Inside Judy Garland's Final Years and Her London Concerts",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/actors/judy-garland-london-concerts-final-years",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Reference article citing her Los Angeles Times obituary and London press reports; used for the coroner's ruling; updated January 14, 2021."
    },
    {
      "source_id": "SRC-0008",
      "title": "Review of Clarke G. Get Happy: The Life of Judy Garland",
      "publisher": "Kirkus Reviews",
      "url": "https://www.kirkusreviews.com/book-reviews/gerald-clarke/get-happy/",
      "source_type": "other",
      "published": "2000-04-01",
      "accessed": "2026-11-04",
      "rights_note": "Book review summarizing the biography; used for her dependence and treatment in her twenties."
    },
    {
      "source_id": "SRC-0009",
      "title": "Review of Clarke G. Get Happy: The Life of Judy Garland",
      "publisher": "Publishers Weekly",
      "url": "https://www.publishersweekly.com/9780375503788",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Book review summarizing the biography; used only for the contested account in CLM-0004."
    },
    {
      "source_id": "SRC-0010",
      "title": "TV Guide, Philadelphia edition, September 24, 1955 (Media History Digital Library)",
      "publisher": "Lantern, Media History Digital Library",
      "url": "https://lantern.mediahist.org/catalog/tvguide-philadelphia-1955-09-24_0007",
      "source_type": "primary",
      "published": "1955-09-24",
      "accessed": "2026-11-04",
      "rights_note": "Contemporary listings magazine, digitized; used for the date of her television debut."
    },
    {
      "source_id": "SRC-0011",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-06-22",
    "index_age": 33,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Iatrogenic dependence and the duty to prescribe controlled drugs safely, especially to minors: nonjudgmental primary care for a 33-year-old singer and actor, three months after childbirth, who has taken prescribed barbiturate sleeping pills and amphetamine since she was a teenager. The episode covers a DSM-5-TR assessment that does not count tolerance and withdrawal from supervised use, the DAST-10, a prescription drug monitoring program review, one prescriber and limited dispensing, a supervised hospital change to phenobarbital because barbiturate withdrawal can cause seizures, a slow outpatient taper that follows the tapering principles of the 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering (which excludes barbiturates) with addiction medicine guidance, a short stimulant taper, CBT for insomnia as first-line treatment instead of another hypnotic, depression and anxiety care with a structured safety assessment, means safety and the 988 Suicide & Crisis Lifeline, contraception that phenobarbital does not weaken, nutrition and weight without stigma, the reason naloxone was not prescribed, and planning around the demands of performing.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-06-22",
        "purpose": "Establishing primary care for long-term prescribed sleeping pills and stimulants that began in adolescence: a nonjudgmental assessment, a prescription drug monitoring program review, sleep, mood, anxiety and safety, nutrition, and contraception three months after childbirth"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-06-29",
        "purpose": "One-week review with the addiction medicine consultation: planning a supervised barbiturate withdrawal"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-07-20",
        "purpose": "Four-week review eleven days after a supervised hospital change from secobarbital to phenobarbital: starting the outpatient taper and the stimulant taper"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-08-17",
        "purpose": "Same-day sick visit for acute laryngitis"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-31",
        "purpose": "Ten-week review: phenobarbital taper, life after stopping the stimulant, sleep, mood, weight and work"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-09-28",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-26",
        "purpose": "Four-month review: phenobarbital taper, sleep, mood, laboratory checks and the plan to finish"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pills",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F13.20",
            "display": "Sedative, hypnotic or anxiolytic dependence, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pills",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F15.10",
            "display": "Other stimulant abuse, uncomplicated",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescence",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G47.00",
            "display": "Insomnia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern diagnosis anchored to the documented sleeping pills.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-005",
        "display": "Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implants",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z30.013",
            "display": "Encounter for initial prescription of injectable contraceptive",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic contraception need; the birth is documented.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-004",
        "display": "Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomania",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F32.1",
            "display": "Major depressive disorder, single episode, moderate",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Acute laryngitis, probably viral, during rehearsals, treated with voice rest and supportive care; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J04.0",
            "display": "Acute laryngitis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic acute illness; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-17"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicine",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312914",
            "display": "secobarbital sodium 100 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two capsules at bedtime; no extra doses"
        },
        "start_date": "2026-06-22",
        "end_date": "2026-07-06",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic long-term barbiturate prescription, anchored to the documented sleeping pills; not stopped abruptly because barbiturate withdrawal can cause seizures and delirium.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energy",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "884385",
            "display": "dextroamphetamine sulfate 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning"
        },
        "start_date": "2026-06-22",
        "end_date": "2026-07-20",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic long-term stimulant prescription, anchored to the documented pep pills; held at one fixed dose until the barbiturate was stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Dextroamphetamine 5 mg oral tablet, one tablet each morning for two weeks, then stop",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "884386",
            "display": "dextroamphetamine sulfate 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning for two weeks, then stop"
        },
        "start_date": "2026-07-20",
        "end_date": "2026-08-03",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic two-week stimulant taper once phenobarbital was stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Sertraline 25 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312940",
            "display": "sertraline 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-06-22",
        "end_date": "2026-06-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic starting dose of an SSRI for depression with anxious distress after the Mood Disorder Questionnaire was negative.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Sertraline 50 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312941",
            "display": "sertraline 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-06-29",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic target dose after a week without side effects.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Phenobarbital 32.4 mg oral tablet, one tablet three times daily (97.2 mg a day), started in hospital in place of secobarbital",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "199167",
            "display": "phenobarbital 32.4 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet three times daily"
        },
        "start_date": "2026-07-06",
        "end_date": "2026-07-20",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic substitution of a long-acting barbiturate during a four-day supervised admission; dispensed one week at a time after discharge.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Phenobarbital 16.2 mg oral tablet on a written taper schedule in two or three divided doses: 81 mg a day from the four-week visit, lowered by 8.1 to 16.2 mg about every two weeks and paused when needed; dispensed two weeks at a time",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198086",
            "display": "phenobarbital 16.2 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "Per the written taper schedule, in two or three divided doses"
        },
        "start_date": "2026-07-20",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic slow outpatient taper of no more than about 20% every two weeks, slower toward the end.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1000126",
            "display": "1 ML medroxyprogesterone acetate 150 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "mL"
        },
        "route": "intramuscular",
        "frequency": {
          "period": 13,
          "period_unit": "wk",
          "text": "150 mg intramuscularly every 13 weeks"
        },
        "start_date": "2026-06-22",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic contraception chosen because barbiturates lower the effectiveness of contraceptive pills, patches, rings and implants; pregnancy test negative first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for throat pain, no more than 3,000 mg a day, for up to five days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Two tablets every 6 hours as needed, up to 3,000 mg a day"
        },
        "start_date": "2026-08-17",
        "end_date": "2026-08-22",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "as_needed": true,
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic non-sedating analgesic for throat pain; phenobarbital induces liver enzymes, so the daily limit is kept at 3,000 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 12.3,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three months after childbirth; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V1",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 86,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three months after childbirth; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 284,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count three months after childbirth; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 24,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ferritin three months after childbirth; low-normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel before phenobarbital.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 4.1,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel before phenobarbital.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 0.66,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel before phenobarbital.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 119,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel before phenobarbital.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 82,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel before phenobarbital.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 21,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline liver tests before phenobarbital, an enzyme inducer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 18,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline liver tests before phenobarbital, an enzyme inducer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V1",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline liver tests before phenobarbital, an enzyme inducer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-22",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH for fatigue, low mood and a fast pulse three months after childbirth; normal, so postpartum thyroiditis is unlikely.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-DAST10-V1",
        "display": "Total score [DAST-10]",
        "label": "DAST-10",
        "status": "final",
        "effective_date": "2026-06-22",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "82667-7",
            "display": "Total score [DAST-10]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic drug-use screen for the past 12 months: substantial problems with prescribed sedatives and stimulants. Not a claim about her real use.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-06-22",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; below the risk threshold for women.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-22",
        "value": 14,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; moderate symptoms; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V1",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-06-22",
        "value": 13,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic anxiety screen; moderate symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-20",
        "value": 12,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 four weeks after starting sertraline and eleven days after the change to phenobarbital; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V3",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-07-20",
        "value": 11,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7; slightly better.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-31",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 after the stimulant was stopped and tiredness eased; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V4",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-08-31",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7; mild symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V6",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-09-28",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 at the preventive visit; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 12.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MCV-V5",
        "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
        "label": "MCV",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 87,
        "unit": "fL",
        "reference_range": {
          "low": 80,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "787-2",
            "display": "MCV [Entitic mean volume] in Red Blood Cells by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 268,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-FERR-V5",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 41,
        "unit": "ng/mL",
        "reference_range": {
          "low": 15,
          "high": 150
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ferritin after diet changes; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on phenobarbital; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on phenobarbital; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 0.68,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on phenobarbital; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 118,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on phenobarbital; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 23,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on phenobarbital: GGT mildly raised by enzyme induction, with normal AST and ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 20,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on phenobarbital: GGT mildly raised by enzyme induction, with normal AST and ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GGT-V5",
        "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "GGT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-26",
        "value": 48,
        "unit": "U/L",
        "reference_range": {
          "low": 5,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2324-2",
            "display": "Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests on phenobarbital: GGT mildly raised by enzyme induction, with normal AST and ALT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; response, nearly in remission; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V5",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-10-26",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7; mild symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram before continuing a stimulant",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-22",
          "end": "2026-06-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline ECG on dextroamphetamine with a pulse of 98: sinus rhythm at 96, normal intervals (QTc 428 ms) (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Medically managed barbiturate withdrawal: four-day hospital admission to the addiction medicine service to change secobarbital to phenobarbital, with withdrawal scoring, seizure precautions and dose stabilization",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "61480009",
            "display": "Drug detoxification",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-06",
          "end": "2026-07-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic supervised withdrawal planned at the consultation; no seizure or delirium occurred.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Advance care planning conversation, about 17 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-09-28",
          "end": "2026-09-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2026-06-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap; none recorded in pregnancy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, inactivated, this season",
        "status": "completed",
        "date": "2026-09-28",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Stimulant pills for appetite and energy and barbiturate sleeping pills given to her as a teenage studio performer, with dependence on prescribed medicines since",
        "historical_date": {
          "iso": "1939",
          "display": "by 1939",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Hospital and sanitarium stays in her twenties, publicly described as treatment for exhaustion",
        "historical_date": {
          "iso": "1949",
          "display": "1949",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Suicide attempts reported publicly, including one in 1950; recorded without detail",
        "historical_date": {
          "iso": "1950",
          "display": "1950",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Birth of her third child three months before the index visit",
        "historical_date": {
          "iso": "1955-03",
          "display": "March 1955",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing primary care for long-term prescribed sleeping pills and stimulants that began in adolescence: a nonjudgmental assessment, a prescription drug monitoring program review, sleep, mood, anxiety and safety, nutrition, and contraception three months after childbirth",
        "status": "finished",
        "date": "2026-06-22",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "One-week review with the addiction medicine consultation: planning a supervised barbiturate withdrawal",
        "status": "finished",
        "date": "2026-06-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "One-week review, seen the same day by addiction medicine",
          "hpi": {
            "narrative": "Ms. Garland returns one week after intake and is seen by Dr. Grünewald of addiction medicine on the same day. She has taken secobarbital 200 mg at bedtime from the seven-day supply on six nights; on one night before a recording session she took a third capsule when she could not sleep, and she told us so herself. She has had no daytime shakes, sweats, or seizure-like episodes. She has taken dextroamphetamine 10 mg each morning and no extra doses, and she has felt flat and tired in the afternoons. She has taken sertraline 25 mg daily without nausea or headache. She brought 38 unused secobarbital capsules and 22 dextroamphetamine tablets from earlier prescriptions, which she placed in the pharmacy take-back box with the nurse today. She keeps this week's supply in a locked box. She has two weeks free of performances from next week and would like to use them for the change.",
            "elements": [
              {
                "label": "Secobarbital",
                "value": "200 mg at bedtime on six nights; 300 mg on one night"
              },
              {
                "label": "Withdrawal symptoms",
                "value": "None"
              },
              {
                "label": "Dextroamphetamine",
                "value": "10 mg each morning; no extra doses"
              },
              {
                "label": "Sertraline",
                "value": "25 mg daily for a week; no side effects"
              },
              {
                "label": "Take-back",
                "value": "38 secobarbital capsules and 22 dextroamphetamine tablets returned today"
              },
              {
                "label": "Work",
                "value": "Two weeks without performances from next week"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired in the afternoons; no fever"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor, unsteadiness or seizure-like episodes"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood and worry, a little better; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert; blood pressure 124/80, pulse 92"
            },
            {
              "system": "Neurological",
              "finding": "No tremor; no nystagmus; gait steady"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and candid; no signs of intoxication or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder with physiological dependence",
              "assessment": "Daily secobarbital 200 to 300 mg for years means a high risk of seizures and delirium if it is stopped or cut quickly. Dr. Grünewald agrees that the change should be made in hospital: a planned four-day admission to the addiction medicine service to change to phenobarbital, a long-acting barbiturate, and find the dose that keeps her free of withdrawal, then a slow outpatient taper. Safety reviewed: no thoughts of suicide or self-harm; the unused capsules are gone and the supply is locked away",
              "plan": [
                "Admission planned for one week from today",
                "Continue secobarbital 200 mg at bedtime until admission, seven days at a time; no alcohol"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Stimulant use disorder (prescribed amphetamine), mild",
              "assessment": "No extra doses this week. Stopping the stimulant can bring tiredness and low mood for a few weeks, so it will be tapered once phenobarbital is stable, not at the same time as the barbiturate change",
              "plan": [
                "Continue dextroamphetamine 10 mg each morning until the four-week visit"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Depression with anxious distress",
              "assessment": "Sertraline 25 mg tolerated for a week",
              "plan": [
                "Increase sertraline to 50 mg daily",
                "Weekly psychotherapy, which she began this week"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Barbiturate dose, adherence, extra doses, and withdrawal signs (tremor, sweating, pulse, sleep, seizure warning signs)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "200 mg on six nights and 300 mg on one; no withdrawal signs",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Setting for barbiturate withdrawal",
              "cadence": "Before any reduction",
              "status": "ordered",
              "detail": "Four-day admission to the addiction medicine service planned for next week, as advised today",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before every controlled-substance prescription",
              "status": "completed_today",
              "detail": "Only this clinic's prescriptions since intake",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, explained as part of care",
              "cadence": "At the start, after the change to phenobarbital, and periodically during the taper",
              "status": "up_to_date",
              "detail": "At intake: barbiturates and amphetamine only; no opioids, fentanyl or benzodiazepines",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Limited dispensing, locked storage and take-back of unused capsules",
              "cadence": "Seven days at first, then two weeks at a time",
              "status": "completed_today",
              "detail": "Seven-day supply; locked box; 38 capsules and 22 tablets taken back today",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Stimulant dose, extra doses, cravings, and blood pressure and pulse",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "10 mg each morning, no extra doses; blood pressure 124/80, pulse 92",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "CBT for insomnia, sleep diary and Insomnia Severity Index",
              "cadence": "Weekly CBT-I sessions; sleep diary and index at each visit",
              "status": "completed_today",
              "detail": "First CBT-I session booked; sleep diary started; Insomnia Severity Index 21 (moderate)",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "New hypnotic (benzodiazepine, Z-drug, trazodone or antihistamine)",
              "cadence": "Not recommended as a replacement",
              "status": "not_indicated",
              "detail": "No new hypnotic during the barbiturate taper",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017",
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression (PHQ-9)",
              "cadence": "At least monthly during acute treatment",
              "status": "up_to_date",
              "detail": "PHQ-9 14 a week ago; next at the four-week visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Sertraline adherence and side effects",
              "cadence": "Two weeks after starting or changing the dose, then each visit",
              "status": "completed_today",
              "detail": "No side effects on 25 mg; increased to 50 mg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, means safety and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "C-SSRS screen negative since the last visit; unused capsules returned; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy",
              "cadence": "Weekly",
              "status": "completed_today",
              "detail": "First session this week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, meals and disordered-eating screen, without a weight target",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Weight 46.8 kg; eating one or two meals a day",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone",
              "cadence": "Reassess at every visit and whenever an opioid is prescribed",
              "status": "not_indicated",
              "detail": "No opioids prescribed or used; naloxone would not reverse a barbiturate",
              "guideline_ids": [
                "GL-ASAM-STIM-2024",
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "referral",
              "measure": "Addiction medicine consultation",
              "cadence": "At the start of treatment",
              "status": "completed_today",
              "detail": "Seen by Dr. Grünewald today",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            }
          ],
          "follow_up": "Hospital admission in one week. Four-week review after discharge. Weekly psychotherapy and CBT-I",
          "guideline_ids": [
            "GL-BZD-TAPER-2025",
            "GL-ASAM-AWM-2020",
            "GL-ASAM-STIM-2024",
            "GL-CDC-PDMP",
            "GL-ACP-INSOMNIA-2016",
            "GL-SUICIDE-2024",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Four-week review eleven days after a supervised hospital change from secobarbital to phenobarbital: starting the outpatient taper and the stimulant taper",
        "status": "finished",
        "date": "2026-07-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Four-week review, eleven days after the supervised change to phenobarbital",
          "hpi": {
            "narrative": "Ms. Garland returns eleven days after a four-day admission to the addiction medicine service. Secobarbital was stopped on admission and phenobarbital was started and adjusted with withdrawal scoring; she had a mild tremor and poor sleep on the second night, no seizure and no confusion, and she was discharged on phenobarbital 32.4 mg three times daily. She has taken it as prescribed from the one-week supply and has taken no secobarbital. She was drowsy for the first three days at home, and that has passed. She sleeps four to five hours a night; her sleep diary shows that she lies awake for an hour after late rehearsals. She has kept to one 10 mg dextroamphetamine tablet each morning. She has taken sertraline 50 mg daily without side effects. Her mood is a little better. The dietitian could not see her yet because of a waiting list.",
            "elements": [
              {
                "label": "Admission",
                "value": "Four days; mild tremor on one night; no seizure or delirium"
              },
              {
                "label": "Phenobarbital",
                "value": "32.4 mg three times daily since discharge"
              },
              {
                "label": "Secobarbital",
                "value": "None since admission"
              },
              {
                "label": "Sleep",
                "value": "Four to five hours; Insomnia Severity Index 18"
              },
              {
                "label": "Dextroamphetamine",
                "value": "10 mg each morning"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 12; GAD-7 11"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Drowsiness after discharge has passed; no fever"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor, unsteadiness or seizure-like episodes since discharge"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Mood low at times, better than at intake; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 118/76, pulse 82; weight 47.6 kg"
            },
            {
              "system": "Neurological",
              "finding": "No tremor or nystagmus; finger-to-nose and gait normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged; no signs of sedation or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder on phenobarbital",
              "assessment": "Stable on 97.2 mg a day with no withdrawal and no sedation, so the outpatient taper can begin. Urine test shows barbiturates, as expected on phenobarbital, and amphetamine. Safety reviewed: no thoughts of suicide or self-harm; supply locked away",
              "plan": [
                "Phenobarbital 16.2 mg tablets on the written taper schedule: 81 mg a day from today (32.4 mg morning, 16.2 mg afternoon, 32.4 mg at bedtime), then 64.8 mg a day in two weeks if she is well, with a nurse phone check before each step",
                "Dispensed two weeks at a time",
                "Call the same day for tremor, sweating, confusion or a seizure"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Stimulant use disorder (prescribed amphetamine), mild",
              "assessment": "Barbiturate now stable, so the stimulant taper starts as planned",
              "plan": [
                "Dextroamphetamine 5 mg each morning for two weeks, then stop",
                "Expect tiredness and more sleep for a week or two; regular meals and daylight walks help"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Chronic insomnia",
              "assessment": "Sleep short, as expected early in the taper. CBT-I has begun",
              "plan": [
                "A fixed wake time, a wind-down hour after late rehearsals, and out of bed when unable to sleep; sleep restriction to wait until the taper is further along"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Depression with anxious distress on sertraline",
              "assessment": "PHQ-9 12 from 14, GAD-7 11 from 13; early improvement three weeks after reaching 50 mg",
              "plan": [
                "Continue sertraline 50 mg daily and weekly psychotherapy"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Barbiturate dose, adherence, extra doses, and withdrawal signs (tremor, sweating, pulse, sleep, seizure warning signs)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Phenobarbital 97.2 mg a day since discharge; no secobarbital; no withdrawal or sedation",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "referral",
              "measure": "Setting for barbiturate withdrawal",
              "cadence": "Before any reduction",
              "status": "completed_today",
              "detail": "Four-day supervised admission completed without a seizure or delirium",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Taper pace",
              "cadence": "Reductions of no more than about 20% every two weeks, slower toward the end; pause for symptoms, illness or a major performance",
              "status": "completed_today",
              "detail": "First step today, 97.2 to 81 mg a day (17%)",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before every controlled-substance prescription",
              "status": "completed_today",
              "detail": "Only the hospital's and this clinic's prescriptions",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, explained as part of care",
              "cadence": "At the start, after the change to phenobarbital, and periodically during the taper",
              "status": "completed_today",
              "detail": "Barbiturates and amphetamine, as prescribed; nothing else",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Limited dispensing, locked storage and take-back of unused capsules",
              "cadence": "Seven days at first, then two weeks at a time",
              "status": "completed_today",
              "detail": "Two-week supply from today; locked box",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Stimulant dose, extra doses, cravings, and blood pressure and pulse",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "10 mg each morning, no extra doses; blood pressure 118/76, pulse 82; taper to 5 mg started",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Electrocardiogram",
              "cadence": "Before continuing a stimulant",
              "status": "up_to_date",
              "detail": "Normal at intake",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "CBT for insomnia, sleep diary and Insomnia Severity Index",
              "cadence": "Weekly CBT-I sessions; sleep diary and index at each visit",
              "status": "completed_today",
              "detail": "Two CBT-I sessions; Insomnia Severity Index 18",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "New hypnotic (benzodiazepine, Z-drug, trazodone or antihistamine)",
              "cadence": "Not recommended as a replacement",
              "status": "not_indicated",
              "detail": "No new hypnotic",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017",
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression (PHQ-9)",
              "cadence": "At least monthly during acute treatment",
              "status": "completed_today",
              "detail": "PHQ-9 12, item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Anxiety (GAD-7)",
              "cadence": "With each PHQ-9 while anxiety is treated",
              "status": "completed_today",
              "detail": "GAD-7 11",
              "observation_ids": [
                "OBS-GAD7-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Sertraline adherence and side effects",
              "cadence": "Two weeks after starting or changing the dose, then each visit",
              "status": "completed_today",
              "detail": "50 mg daily for three weeks; no side effects",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, means safety and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "C-SSRS screen negative since the last visit; safety plan reviewed; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychotherapy",
              "cadence": "Weekly",
              "status": "completed_today",
              "detail": "Weekly sessions continuing",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, meals and disordered-eating screen, without a weight target",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Weight 47.6 kg, up 1.1 kg; two meals a day",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Dietitian visit",
              "cadence": "Within a month of intake",
              "status": "deferred",
              "detail": "Not yet seen four weeks after intake because of a waiting list. No harm so far: weight is rising and she is eating more. Corrective action: the clinic booked a second dietitian with an earlier opening",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception that phenobarbital does not weaken",
              "cadence": "Medroxyprogesterone every 13 weeks",
              "status": "up_to_date",
              "detail": "First injection at intake; next due in about nine weeks",
              "guideline_ids": [
                "GL-CDC-MEC-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone",
              "cadence": "Reassess at every visit and whenever an opioid is prescribed",
              "status": "not_indicated",
              "detail": "No opioids prescribed or used",
              "guideline_ids": [
                "GL-ASAM-STIM-2024",
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Work schedule and driving safety",
              "cadence": "With each dose change",
              "status": "completed_today",
              "detail": "No driving while drowsy; taper steps planned for weeks without major performances",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            }
          ],
          "follow_up": "Nurse phone check before each taper step. Ten-week review in six weeks. Weekly psychotherapy and CBT-I",
          "guideline_ids": [
            "GL-BZD-TAPER-2025",
            "GL-ASAM-AWM-2020",
            "GL-ASAM-STIM-2024",
            "GL-CDC-PDMP",
            "GL-ACP-INSOMNIA-2016",
            "GL-AASM-INSOMNIA-2017",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CDC-MEC-2024"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Ten-week review: phenobarbital taper, life after stopping the stimulant, sleep, mood, weight and work",
        "status": "finished",
        "date": "2026-08-31",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Ten-week review: phenobarbital taper, four weeks after stopping dextroamphetamine",
          "hpi": {
            "narrative": "Ms. Garland returns six weeks after her four-week review. She took the last dextroamphetamine tablet four weeks ago. For about two weeks afterwards she was tired, slept more and felt flat, and then her energy returned; she has had occasional urges to take a pill before rehearsals and has not acted on them. Her appetite has come back and she eats three meals on most days. She has gained 1.3 kg since the last visit, and she worries about it; we talked about it without a target. The step to 64.8 mg of phenobarbital went smoothly. Two weeks ago, at the sick visit for laryngitis, the next step was paused; her voice recovered within six days and she is back to singing. She sleeps about six hours on most nights. She saw the dietitian last week. Her mood is better.",
            "elements": [
              {
                "label": "Dextroamphetamine",
                "value": "Stopped four weeks ago; two weeks of tiredness, then better"
              },
              {
                "label": "Phenobarbital",
                "value": "64.8 mg a day for four weeks; step paused at the sick visit"
              },
              {
                "label": "Laryngitis",
                "value": "Resolved in six days"
              },
              {
                "label": "Sleep",
                "value": "About six hours; Insomnia Severity Index 13"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 9; GAD-7 8"
              },
              {
                "label": "Weight",
                "value": "48.9 kg; three meals on most days"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy back to her usual; no fever"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Voice recovered; no sore throat"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor or seizure-like episodes"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Occasional urges to take a stimulant before rehearsals; mood better; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 112/72, pulse 72; weight 48.9 kg, BMI 21.4"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Voice clear; throat normal"
            },
            {
              "system": "Neurological",
              "finding": "No tremor or nystagmus"
            },
            {
              "system": "Psychiatric",
              "finding": "Brighter; no signs of sedation or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder on a phenobarbital taper",
              "assessment": "Stable at 64.8 mg a day after the pause. Safety reviewed: no thoughts of suicide or self-harm; supply locked away",
              "plan": [
                "Lower phenobarbital to 56.7 mg a day today (24.3 mg morning, 32.4 mg at bedtime), then 48.6 mg a day in two weeks and 40.5 mg a day at the preventive visit, if she is well"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Stimulant use disorder, mild, in early remission",
              "assessment": "No stimulant for four weeks after the taper; occasional urges managed with her therapist. Pulse 72 off the stimulant",
              "plan": [
                "No stimulant prescriptions; she will tell us if urges grow"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Depression with anxious distress on sertraline",
              "assessment": "PHQ-9 9 and GAD-7 8, improving through the end of the stimulant. The PHQ-9 was not repeated for six weeks, longer than the monthly check advised in acute treatment; no harm resulted, since her weekly therapist saw no worsening and today's score is lower",
              "plan": [
                "Continue sertraline 50 mg daily",
                "PHQ-9 at the preventive visit in four weeks and monthly after that"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Chronic insomnia",
              "assessment": "Insomnia Severity Index 13 from 21; CBT-I helping",
              "plan": [
                "Begin a gentle sleep window of six and a half hours, set with her CBT-I therapist around performances"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Barbiturate dose, adherence, extra doses, and withdrawal signs (tremor, sweating, pulse, sleep, seizure warning signs)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "64.8 mg a day; no withdrawal signs",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Taper pace",
              "cadence": "Reductions of no more than about 20% every two weeks, slower toward the end; pause for symptoms, illness or a major performance",
              "status": "completed_today",
              "detail": "81 to 64.8 mg two weeks after the first step; paused at the sick visit; 64.8 to 56.7 mg today (12.5%)",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before every controlled-substance prescription",
              "status": "completed_today",
              "detail": "Only this clinic's prescriptions; no opioid from the sick visit",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, explained as part of care",
              "cadence": "At the start, after the change to phenobarbital, and periodically during the taper",
              "status": "up_to_date",
              "detail": "Last at the four-week visit; next at four months",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Limited dispensing, locked storage and take-back of unused capsules",
              "cadence": "Seven days at first, then two weeks at a time",
              "status": "completed_today",
              "detail": "Two-week supplies; locked box",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Mood, sleep, energy and appetite after stopping the stimulant",
              "cadence": "Weekly for the first month after stopping, then each visit",
              "status": "completed_today",
              "detail": "Two weeks of tiredness and flat mood, then better; appetite back; occasional urges",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Electrocardiogram",
              "cadence": "Before continuing a stimulant",
              "status": "not_indicated",
              "detail": "Stimulant stopped",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "CBT for insomnia, sleep diary and Insomnia Severity Index",
              "cadence": "Weekly CBT-I sessions; sleep diary and index at each visit",
              "status": "completed_today",
              "detail": "Weekly sessions; Insomnia Severity Index 13",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "New hypnotic (benzodiazepine, Z-drug, trazodone or antihistamine)",
              "cadence": "Not recommended as a replacement",
              "status": "not_indicated",
              "detail": "No new hypnotic",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017",
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression (PHQ-9)",
              "cadence": "At least monthly during acute treatment",
              "status": "deferred",
              "detail": "PHQ-9 9 today, six weeks after the last score, longer than the monthly check advised; the sick visit did not repeat it. No harm resulted: her weekly therapist saw no worsening and today's score is lower. Corrective action: PHQ-9 at the preventive visit and monthly after that",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Anxiety (GAD-7)",
              "cadence": "With each PHQ-9 while anxiety is treated",
              "status": "completed_today",
              "detail": "GAD-7 8",
              "observation_ids": [
                "OBS-GAD7-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Sertraline adherence and side effects",
              "cadence": "Two weeks after starting or changing the dose, then each visit",
              "status": "completed_today",
              "detail": "50 mg daily; no side effects",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, means safety and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "C-SSRS screen negative since the last visit; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, meals and disordered-eating screen, without a weight target",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Weight 48.9 kg, BMI 21.4; three meals on most days; discussed without a target",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Dietitian visit",
              "cadence": "Within a month of intake",
              "status": "completed_today",
              "detail": "Seen last week by the second dietitian; plan for meals around rehearsals",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception that phenobarbital does not weaken",
              "cadence": "Medroxyprogesterone every 13 weeks",
              "status": "due",
              "detail": "Second injection due at the preventive visit in four weeks",
              "guideline_ids": [
                "GL-CDC-MEC-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone",
              "cadence": "Reassess at every visit and whenever an opioid is prescribed",
              "status": "not_indicated",
              "detail": "No opioids prescribed or used; codeine was avoided at the sick visit",
              "guideline_ids": [
                "GL-ASAM-STIM-2024",
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol and other sedatives",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol; no other sedatives or sleep aids",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            }
          ],
          "follow_up": "Nurse phone check before each taper step. Preventive visit in four weeks with the PHQ-9 and the second contraceptive injection. Four-month review in eight weeks with laboratory checks",
          "guideline_ids": [
            "GL-BZD-TAPER-2025",
            "GL-ASAM-STIM-2024",
            "GL-CDC-PDMP",
            "GL-ACP-INSOMNIA-2016",
            "GL-AASM-INSOMNIA-2017",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CDC-MEC-2024"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Four-month review: phenobarbital taper, sleep, mood, laboratory checks and the plan to finish",
        "status": "finished",
        "date": "2026-10-26",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Four-month review: phenobarbital taper, sleep, mood and laboratory checks",
          "hpi": {
            "narrative": "Ms. Garland returns four weeks after her preventive visit. She lowered phenobarbital to 40.5 mg a day at that visit and to 32.4 mg a day two weeks ago. After the last step she lay awake for three nights and felt shaky inside, without a tremor others could see; it has eased but not fully gone, and she would like to stay at this dose for a while. She has taken no secobarbital, stimulant or other sedative. She sleeps about six hours on most nights. Her mood is good and she is enjoying work again. She eats three meals on most days and says she feels stronger. Her HIV, hepatitis C and hepatitis B tests from the preventive visit were nonreactive, and she was told by phone. She wants to talk about stopping smoking once the taper is over.",
            "elements": [
              {
                "label": "Phenobarbital",
                "value": "32.4 mg a day for two weeks; three nights of rebound wakefulness after the step"
              },
              {
                "label": "Other sedatives or stimulants",
                "value": "None"
              },
              {
                "label": "Sleep",
                "value": "About six hours; Insomnia Severity Index 10"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 5; GAD-7 5"
              },
              {
                "label": "Screening results",
                "value": "HIV, hepatitis C and hepatitis B nonreactive"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Energy good; weight up gradually"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No visible tremor or seizure-like episodes; brief inner shakiness after the last step, easing"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 5; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 112/70, pulse 68; weight 50.0 kg, BMI 21.9"
            },
            {
              "system": "Neurological",
              "finding": "No tremor with arms outstretched; no nystagmus"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright and engaged; no signs of sedation or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder on a phenobarbital taper",
              "assessment": "From 97.2 to 32.4 mg a day over fourteen weeks without a seizure or a return to secobarbital. The last step brought mild rebound wakefulness, so the taper is paused, as she asked. Urine test shows barbiturates only. Blood count normal; AST 23 and ALT 20 U/L normal; GGT 48 U/L, mildly raised by phenobarbital's effect on the liver's enzymes, to be rechecked after the taper. Safety reviewed: no thoughts of suicide or self-harm",
              "plan": [
                "Hold phenobarbital at 32.4 mg a day for four weeks, then 24.3, 16.2 and 8.1 mg a day, each for two to four weeks, and stop",
                "Addiction medicine review by video with Dr. Grünewald when the taper ends",
                "Repeat liver tests three months after stopping"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Stimulant use disorder, mild, in early remission",
              "assessment": "No stimulant for twelve weeks; urine test negative for amphetamine",
              "plan": [
                "No stimulant prescriptions"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Depression with anxious distress on sertraline",
              "assessment": "PHQ-9 5 from 14 and GAD-7 5 from 13: a good response, close to remission",
              "plan": [
                "Continue sertraline 50 mg daily for at least six to twelve months after remission",
                "Psychotherapy every two weeks"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Chronic insomnia",
              "assessment": "Insomnia Severity Index 10 from 21; about six hours of sleep",
              "plan": [
                "Continue CBT-I every two weeks through the end of the taper"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "medication_safety",
              "measure": "Barbiturate dose, adherence, extra doses, and withdrawal signs (tremor, sweating, pulse, sleep, seizure warning signs)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "32.4 mg a day; mild rebound wakefulness after the last step; no tremor or other withdrawal signs",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Taper pace",
              "cadence": "Reductions of no more than about 20% every two weeks, slower toward the end; pause for symptoms, illness or a major performance",
              "status": "completed_today",
              "detail": "56.7 to 48.6 to 40.5 to 32.4 mg a day at two-week intervals; paused today for four weeks; later steps of 8.1 mg",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Prescription drug monitoring program check",
              "cadence": "Before every controlled-substance prescription",
              "status": "completed_today",
              "detail": "Only this clinic's prescriptions",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine drug testing, explained as part of care",
              "cadence": "At the start, after the change to phenobarbital, and periodically during the taper",
              "status": "completed_today",
              "detail": "Barbiturates only; amphetamine negative",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Limited dispensing, locked storage and take-back of unused capsules",
              "cadence": "Seven days at first, then two weeks at a time",
              "status": "completed_today",
              "detail": "Two-week supplies; locked box",
              "guideline_ids": [
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Mood, sleep, energy and appetite after stopping the stimulant",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No stimulant for twelve weeks; urges rare",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count and liver tests on phenobarbital",
              "cadence": "Baseline, then at three to four months",
              "status": "completed_today",
              "detail": "Hemoglobin 12.9 g/dL, MCV 87 fL, platelets 268; ferritin 41 ng/mL; sodium 140, potassium 4.2, creatinine 0.68 mg/dL, eGFR 118; AST 23, ALT 20 U/L; GGT 48 U/L, mildly raised by enzyme induction",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-MCV-V5",
                "OBS-PLT-V5",
                "OBS-FERR-V5",
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-AST-V5",
                "OBS-ALT-V5",
                "OBS-GGT-V5"
              ],
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "CBT for insomnia, sleep diary and Insomnia Severity Index",
              "cadence": "Weekly CBT-I sessions; sleep diary and index at each visit",
              "status": "completed_today",
              "detail": "Insomnia Severity Index 10",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "New hypnotic (benzodiazepine, Z-drug, trazodone or antihistamine)",
              "cadence": "Not recommended as a replacement",
              "status": "not_indicated",
              "detail": "No new hypnotic",
              "guideline_ids": [
                "GL-ACP-INSOMNIA-2016",
                "GL-AASM-INSOMNIA-2017",
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression (PHQ-9)",
              "cadence": "At least monthly during acute treatment",
              "status": "completed_today",
              "detail": "PHQ-9 5, item 9 scored 0; monthly since the corrective action",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Anxiety (GAD-7)",
              "cadence": "With each PHQ-9 while anxiety is treated",
              "status": "completed_today",
              "detail": "GAD-7 5",
              "observation_ids": [
                "OBS-GAD7-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Sertraline adherence and side effects",
              "cadence": "Two weeks after starting or changing the dose, then each visit",
              "status": "completed_today",
              "detail": "50 mg daily; no side effects",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, means safety and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "C-SSRS screen negative since the last visit; the 988 Suicide & Crisis Lifeline in her phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, meals and disordered-eating screen, without a weight target",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Weight 50.0 kg, BMI 21.9; three meals on most days; she feels stronger",
              "guideline_ids": [
                "GL-ASAM-STIM-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Contraception that phenobarbital does not weaken",
              "cadence": "Medroxyprogesterone every 13 weeks",
              "status": "up_to_date",
              "detail": "Second injection at the preventive visit; next due in nine weeks",
              "guideline_ids": [
                "GL-CDC-MEC-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Naloxone",
              "cadence": "Reassess at every visit and whenever an opioid is prescribed",
              "status": "not_indicated",
              "detail": "No opioids prescribed or used",
              "guideline_ids": [
                "GL-ASAM-STIM-2024",
                "GL-CDC-PDMP",
                "GL-BZD-TAPER-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol and other sedatives",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol; no other sedatives",
              "guideline_ids": [
                "GL-BZD-TAPER-2025",
                "GL-ASAM-AWM-2020"
              ]
            }
          ],
          "follow_up": "Nurse phone check before each remaining step. Visit in four weeks to restart the taper. Addiction medicine review when the taper ends. Smoking cessation plan at the end of the taper",
          "guideline_ids": [
            "GL-BZD-TAPER-2025",
            "GL-ASAM-AWM-2020",
            "GL-ASAM-STIM-2024",
            "GL-CDC-PDMP",
            "GL-ACP-INSOMNIA-2016",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-CDC-MEC-2024"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-28",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in the waiting room and reviewed with her by Dr. Ellsworth-Diaz",
          "hpi": {
            "narrative": "Ms. Garland is a 33-year-old singer and actor with a barbiturate use disorder on a phenobarbital taper, a mild stimulant use disorder in early remission, chronic insomnia, and depression with anxiety on sertraline, who comes for her yearly preventive visit four weeks after her ten-week review and six months after the birth of her third child. She has followed the written taper schedule: the step two weeks ago went smoothly, and today is her next planned step, to 40.5 mg a day. She has taken no secobarbital, dextroamphetamine, or any other sedative or stimulant. She sleeps about six hours on most nights with her CBT-I routine and a fixed wake time, even after late rehearsals. Her mood and worry are better, and her PHQ-9 today is 7. She eats three meals on most days. She is due for her second contraceptive injection. She still smokes about ten cigarettes a day.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 33"
              },
              {
                "label": "Phenobarbital",
                "value": "48.6 mg a day; step to 40.5 mg a day today per the written schedule"
              },
              {
                "label": "Other sedatives or stimulants",
                "value": "None"
              },
              {
                "label": "Sleep",
                "value": "About six hours on most nights"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 7; item 9 scored 0"
              },
              {
                "label": "Medicines",
                "value": "Phenobarbital 16.2 mg tablets on the taper schedule; sertraline 50 mg daily; medroxyprogesterone injection every 13 weeks"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and better than in the summer"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy with work and three children, with help at home; weekly psychotherapy; a close friend she confides in"
            },
            {
              "domain": "Substance use",
              "finding": "Prescribed phenobarbital on a taper only; no other sedatives or stimulants; a glass of wine a week before the taper and none since"
            },
            {
              "domain": "Tobacco",
              "finding": "About ten cigarettes a day"
            },
            {
              "domain": "Physical activity",
              "finding": "Rehearsals and dance practice most days; walks on days off"
            },
            {
              "domain": "Nutrition",
              "finding": "Three meals on most days and snacks around rehearsals"
            },
            {
              "domain": "Sleep",
              "finding": "About six hours on most nights"
            },
            {
              "domain": "Sexual and reproductive health",
              "finding": "Not planning a pregnancy; on injectable contraception"
            },
            {
              "domain": "Safety at home",
              "finding": "Feels safe at home; no one hurts or threatens her"
            },
            {
              "domain": "Road safety",
              "finding": "Wears a seat belt; does not drive after evening doses"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Oral health",
              "finding": "Dental visit in the past year"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; weight up gradually, which she is comfortable with"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No vision change"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Voice fully recovered since the laryngitis"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain or change in bowel habit"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Irregular light spotting on the injection; no pelvic pain"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor, unsteadiness, or seizure-like episodes"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood better; PHQ-9 7; no thoughts of suicide or self-harm; no cravings for secobarbital"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 49.4 kg, BMI 21.7; blood pressure 110/70; pulse 70"
            },
            {
              "system": "Eyes",
              "finding": "No nystagmus"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender"
            },
            {
              "system": "Skin",
              "finding": "No rash"
            },
            {
              "system": "Neurological",
              "finding": "No tremor; gait and finger-to-nose testing normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Bright and engaged; no signs of sedation or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B screening are due once; cervical screening is up to date",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder on a phenobarbital taper",
              "assessment": "Following the schedule without withdrawal signs. Safety reviewed: no thoughts of suicide or self-harm; the supply is kept in a locked box, and she has the 988 Suicide & Crisis Lifeline in her phone",
              "plan": [
                "Lower phenobarbital to 40.5 mg a day today (16.2 mg morning and 24.3 mg at bedtime)",
                "Next step in two weeks if she is well; four-month review in four weeks"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Contraception on an enzyme-inducing drug",
              "assessment": "Second medroxyprogesterone injection due; light spotting is common and expected",
              "plan": [
                "Medroxyprogesterone 150 mg intramuscularly today",
                "Calcium and vitamin D from food; weight-bearing exercise"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "110/70 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "up_to_date",
              "detail": "Normal cervical cytology with HPV testing during prenatal care last year; next in five years",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "HIV screening",
              "status": "ordered",
              "detail": "Once for all adults; drawn today with her agreement",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "ordered",
              "detail": "Once for all adults; drawn today",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "ordered",
              "detail": "Triple panel once for all adults; drawn today",
              "guideline_ids": [
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Chlamydia and gonorrhea screening",
              "status": "not_indicated",
              "detail": "Age over 24 with one long-term partner and no new risk",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Intimate partner violence screening",
              "status": "completed_today",
              "detail": "Negative; she feels safe at home",
              "guideline_ids": [
                "GL-USPSTF-IPV-2018"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-9 7, from 14 at intake; item 9 scored 0; in treatment",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol and drug use",
              "status": "up_to_date",
              "detail": "AUDIT-C 2 and DAST-10 6 at intake; in treatment; no alcohol during the taper",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco cessation",
              "status": "declined",
              "detail": "About ten cigarettes a day; nicotine replacement and counseling offered; she would like to finish the taper first and will be asked again at the next visit",
              "guideline_ids": [
                "GL-USPSTF-TOB-2021"
              ]
            },
            {
              "service": "Contraception",
              "status": "completed_today",
              "detail": "Second medroxyprogesterone injection; phenobarbital does not weaken it",
              "guideline_ids": [
                "GL-CDC-MEC-2024"
              ]
            },
            {
              "service": "Diabetes and cholesterol screening",
              "status": "not_indicated",
              "detail": "Diabetes screening begins at 35 for adults with overweight; statin assessment begins at 40",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast and colorectal cancer screening",
              "status": "not_indicated",
              "detail": "Begin at 40 and 45",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Influenza vaccine, this season",
              "status": "completed_today",
              "detail": "Given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "declined",
              "detail": "Discussed; she will decide at the next visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap at intake",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "declined",
              "detail": "Shared decision-making for adults 27 to 45; she chose not to have it",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 17 minutes, with her consent. She named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. She said that what matters most to her is her children, her work, and being treated as a person rather than a problem. She asked that, if she were ever too ill to speak for herself, her treatment for the pills be continued without blame. She chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness.",
          "follow_up": "Four-month review in four weeks with blood count, ferritin, metabolic panel and liver tests. HIV, hepatitis C and hepatitis B results by phone. Next contraceptive injection in 13 weeks. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026",
            "GL-SUICIDE-2024",
            "GL-BZD-TAPER-2025"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Same-day sick visit for acute laryngitis",
        "status": "finished",
        "date": "2026-08-17",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Hoarse voice and sore throat for three days, during rehearsals",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Ms. Garland asked for a same-day visit because her voice has been hoarse for three days. It began with a sore throat and a runny nose after several people in her rehearsal company had colds. Yesterday her voice cracked on high notes and today she can speak only quietly. She has a mild dry cough, worse at night, and felt warm yesterday. She has no trouble swallowing or breathing, no drooling, no neck swelling, and no heartburn. She has kept singing in rehearsals. She is taking phenobarbital 64.8 mg a day, and her next planned step down is due today. She asked for a steroid shot to get her voice back for rehearsals and for codeine cough syrup to help her sleep through the cough. She has taken no other medicine for it.",
            "elements": [
              {
                "label": "Onset",
                "value": "Three days ago, after a cold"
              },
              {
                "label": "Location",
                "value": "Throat and voice"
              },
              {
                "label": "Duration",
                "value": "Three days"
              },
              {
                "label": "Character",
                "value": "Hoarse, quiet voice; scratchy sore throat"
              },
              {
                "label": "Severity",
                "value": "Moderate; can speak quietly but cannot sing"
              },
              {
                "label": "Timing",
                "value": "Constant; cough worse at night"
              },
              {
                "label": "Context",
                "value": "Colds in her rehearsal company; she kept singing in rehearsals"
              },
              {
                "label": "Modifying factors",
                "value": "Better with warm drinks; worse with singing"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Runny nose, mild dry cough, felt warm; no trouble swallowing or breathing, no drooling, no heartburn"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Felt warm yesterday; no rigors"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Hoarse voice, sore throat and runny nose; no trouble swallowing, no ear pain"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Mild dry cough; no breathlessness or wheeze"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried about rehearsals and about sleeping with the cough; no thoughts of suicide or self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well-appearing; speaks in a soft, hoarse voice; temperature 37.6 °C, pulse 84, blood pressure 116/74, oxygen saturation 98%"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Mild redness of the throat without exudate; tonsils not enlarged; nasal mucosa swollen with clear discharge; ear drums normal"
            },
            {
              "system": "Neck",
              "finding": "Small tender nodes on both sides; no stridor; neck supple"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation; no wheeze"
            },
            {
              "system": "Neurological",
              "finding": "No tremor"
            },
            {
              "system": "Psychiatric",
              "finding": "Anxious about work; no signs of sedation or withdrawal"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-006",
              "display": "Acute laryngitis, probably viral",
              "assessment": "Hoarseness of three days after a cold, without stridor, trouble swallowing, or signs of a bacterial infection. Hoarseness of less than four weeks after a cold does not need laryngoscopy unless it persists or there are warning signs. Antibiotics do not help. A steroid is not used routinely for acute laryngitis and was not given: it would not shorten a viral illness much, can affect mood and sleep during her taper, and should not be given without examining the vocal folds",
              "plan": [
                "Voice rest for three days, no singing until the voice returns, then a gradual return to singing; no whispering",
                "Fluids, humidified air and honey for the cough",
                "Acetaminophen 1,000 mg every 6 hours as needed, no more than 3,000 mg a day",
                "Laryngoscopy by an otolaryngologist if the hoarseness lasts four weeks, or sooner for stridor, trouble swallowing, coughing up blood or a high fever"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Barbiturate use disorder on a phenobarbital taper",
              "assessment": "Codeine was not prescribed: an opioid added to phenobarbital deepens sedation and slows breathing, and dextromethorphan was also avoided while she is on a sedative. Because she is unwell, worried and sleeping poorly, today's planned step down is paused for two weeks, as the taper plan allows. Naloxone remains not indicated because no opioid has been prescribed. Safety reviewed: no thoughts of suicide or self-harm; the supply is in the locked box",
              "plan": [
                "Hold phenobarbital at 64.8 mg a day for two weeks; next step at the ten-week visit",
                "No codeine, dextromethorphan, antihistamine sleep aids or alcohol",
                "Her CBT-I routine continues; a cough at night is expected to settle within days"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Depression with anxiety on sertraline",
              "assessment": "Worried about work; mood otherwise steady",
              "plan": [
                "Continue sertraline 50 mg daily",
                "A note to her company asking for three days off singing, with the reason given as a voice illness only, as she asked"
              ]
            }
          ],
          "follow_up": "Phone check in three days. Ten-week review in two weeks. Return sooner for trouble breathing or swallowing, or a high fever",
          "guideline_ids": [
            "GL-AAOHNS-DYSPHONIA-2018",
            "GL-BZD-TAPER-2025",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-06-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 46.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 98,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-06-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 46.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-07-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 47.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-31",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 48.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-26",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 50.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-09-28",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 49.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 110,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-08-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 151,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 48.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit: low-grade temperature.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Singer and actor who has performed since early childhood and worked for a film studio from 13; recently finished a major film; preparing for concert and television work, with long rehearsal days and late performances",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Has been given pills for energy, appetite and sleep since she was a girl, and says she cannot remember sleeping without one; currently fills prescriptions from three prescribers at two pharmacies; no pills from any other source",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern medication history anchored to the documented pills given in adolescence; written without judgment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives with her family, including a baby born three months ago; has help at home at night; not breastfeeding",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic household history; no family member is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Alcohol: a glass of wine about once a week (AUDIT-C 2); agrees to no alcohol while taking a barbiturate",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Tobacco: about ten cigarettes a day; wants to deal with the pills first",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic tobacco history; no tobacco diagnosis is coded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Eats one real meal a day on working days and skips meals on the stimulant; worried about gaining weight because she has been told about her weight since childhood",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic nutrition history, recorded without stigma, anchored to the documented use of pills to control her appetite.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Strengths: her work and her audience, her humor, wanting to be well for her children, and a close friend who knows about the pills",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths; no person is named.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities; groggy in the mornings and tired in the afternoons; works long days",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, warm and quick, anxious at first and then candid; speech normal in rate; no signs of intoxication or withdrawal",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood low and worried; PHQ-9 14 with item 9 scored 0, GAD-7 13; Mood Disorder Questionnaire negative; no thoughts of suicide or self-harm now",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-06-22",
      "current_ideation": "absent",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "Her children and her wish to be well for them",
        "Her work and her audience",
        "A close friend who knows about the pills",
        "Her own decision to seek help now",
        "Engagement in primary care and the addiction medicine plan"
      ],
      "disposition": "Outpatient care with close follow-up. Risk factors reviewed without detail: past suicide attempts reported in earlier years, a sedative use disorder, depression, the months after childbirth, and the low mood that can follow stopping a stimulant. Barbiturates are dangerous in overdose, so means safety is part of the plan: she agreed to take the unused capsules from earlier prescriptions to a pharmacy take-back at the next visit, to keep the current supply in a locked box, and to receive no more than seven days at a time. No alcohol with the barbiturate. A written safety plan was made with her, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in her phone. Safety is reviewed at every visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0006"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the substance use and depression codes; it records no current suicidal ideation and makes no claim about her real mental health.",
        "author": "The Human Record generator",
        "created": "2026-11-04T18:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Long-term dependence on prescribed secobarbital and dextroamphetamine that began with pills given to her as a teenage performer, in a 33-year-old singer three months after childbirth, with depression and anxiety. Please confirm the diagnoses and advise on a safe way to withdraw the barbiturate and stop the stimulant",
        "urgency": "Within one week, on the same day as her one-week primary care visit",
        "pertinent_history": "Given stimulant and sleeping pills since her teens; for years she has taken secobarbital 200 mg at bedtime, sometimes 300 mg, and dextroamphetamine 10 mg each morning with extra tablets on long working days, from three prescribers at two pharmacies, as the prescription drug monitoring program confirms. She has tried to cut down on her own and could not sleep. No opioids, benzodiazepines or pills from outside a pharmacy; urine drug test shows barbiturates and amphetamine only. No withdrawal seizures known. DAST-10 6, AUDIT-C 2. PHQ-9 14 (item 9 scored 0), GAD-7 13, Mood Disorder Questionnaire negative; structured safety assessment shows no current suicidal thoughts; suicide attempts were reported in earlier years. Third child born three months ago; not breastfeeding; pregnancy test negative. Pulse 98, blood pressure 128/84; ECG normal. Today: prescriptions moved to this clinic alone, seven days at a time; secobarbital continued at 200 mg at bedtime and dextroamphetamine at 10 mg each morning with no extra doses; sertraline 25 mg started; medroxyprogesterone injection given; CBT for insomnia and psychotherapy arranged. Blood test results from today attached",
        "questions": [
          "Does she meet criteria for sedative-hypnotic and stimulant use disorders, given that these medicines were prescribed?",
          "How should the barbiturate be withdrawn safely: in hospital or as an outpatient, with which medicine, and at what pace?",
          "Should the stimulant be stopped, and at the same time as the barbiturate or afterwards?",
          "How should we treat her insomnia, depression and anxiety during the taper, and what should we avoid?",
          "Does she need naloxone, and what monitoring do you advise?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Garland, a 33-year-old singer and actor, is seen at the request of Dr. Ellsworth-Diaz. She was given pills for energy and sleep from her early teens and has taken them ever since. For years she has taken secobarbital 200 mg at bedtime, and up to 300 mg before important days, and dextroamphetamine each morning with extra tablets on long working days. In the past week, on a single prescriber and seven-day supplies, she took 200 mg on six nights and 300 mg on one, and dextroamphetamine 10 mg each morning. She has tried to stop on her own several times and could not sleep for days. She has never had a seizure. She feels ashamed and wants to stop. She has two weeks free of performances starting next week",
        "data_reviewed": "Dr. Ellsworth-Diaz's intake note, safety assessment, DAST-10 6, AUDIT-C 2, PHQ-9 14, GAD-7 13 and negative Mood Disorder Questionnaire. Prescription drug monitoring program: three prescribers and two pharmacies before intake, only this clinic since. Urine drug test at intake: barbiturates and amphetamine only. Last week's results: hemoglobin 12.3 g/dL, platelets 284, sodium 139, potassium 4.1, creatinine 0.66 mg/dL, eGFR 119, glucose 82 mg/dL, AST 21, ALT 18 and GGT 24 U/L, TSH 1.9 mIU/L, ferritin 24 ng/mL. ECG: sinus rhythm, QTc 428 ms",
        "exam": [
          {
            "system": "General",
            "finding": "Alert; blood pressure 124/80, pulse 92"
          },
          {
            "system": "Neurological",
            "finding": "No tremor; no nystagmus; gait steady"
          },
          {
            "system": "Psychiatric",
            "finding": "Engaged and candid; anxious; no signs of intoxication or withdrawal"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate",
            "assessment": "Tolerance and withdrawal are not counted for a medicine taken under medical supervision. She still meets five criteria: taking more than intended, unsuccessful efforts to cut down, craving, a great deal of time spent getting prescriptions from several prescribers, and continued use despite knowing that it causes morning grogginess and worsens her low mood. That is a moderate use disorder, with physiological dependence. It began with pills given to her as a minor, and that should be said plainly to her: this is harm done to her, not a failing of hers"
          },
          {
            "problem_id": "PRB-001",
            "display": "Barbiturate withdrawal risk",
            "assessment": "Daily short-acting barbiturate at 200 to 300 mg for years carries a real risk of seizures and delirium if it is stopped or cut quickly. The 2025 joint benzodiazepine tapering guideline does not cover barbiturates, but its principles apply: no abrupt stop, a long-acting agent, slow reductions she agrees to, pauses when needed, and inpatient care when severe withdrawal is likely. Phenobarbital, at about 30 mg for each 100 mg of secobarbital, is the usual long-acting substitute and should be started under supervision by clinicians experienced in its use"
          },
          {
            "problem_id": "PRB-002",
            "display": "Stimulant use disorder (prescribed amphetamine), mild",
            "assessment": "Two criteria: extra doses beyond the prescription and unsuccessful efforts to cut down. No medicine is approved for stimulant use disorder, and there is no medical indication to continue it. Stopping can bring tiredness, sleepiness and low mood for a few weeks, so it should not be stopped during the barbiturate change; a short taper once phenobarbital is stable is reasonable"
          },
          {
            "problem_id": "PRB-004",
            "display": "Depression with anxious distress",
            "assessment": "Sertraline is a good choice; phenobarbital may lower its level a little, so the dose should follow her response. Psychotherapy and CBT for insomnia support the taper. Avoid benzodiazepines, Z-drugs, trazodone and sedating antihistamines for sleep, which would swap one sedative for another"
          },
          {
            "display": "Naloxone and monitoring",
            "assessment": "Naloxone reverses opioids, not barbiturates. She takes no opioid and has none in the monitoring program, and her pills all come from pharmacies, so naloxone is not needed now; it should be offered at once if an opioid is ever prescribed. Overdose risk from the barbiturate is lowered by limited supplies, locked storage, no alcohol, and the safety plan"
          }
        ],
        "recommendations": [
          "Admit for about four days to the addiction medicine service in the coming free week: stop secobarbital, start phenobarbital (starting near 30 mg three times daily), adjust with withdrawal scoring and seizure precautions, and discharge on the dose that keeps her free of withdrawal",
          "Then taper phenobarbital as an outpatient by no more than about 20% every two weeks, slower toward the end; pause for withdrawal symptoms, illness or a major performance; never stop abruptly",
          "Keep dextroamphetamine at 10 mg each morning with no extra doses until phenobarbital is stable, then 5 mg for two weeks and stop; check mood, sleep and appetite weekly for the first month",
          "Increase sertraline to 50 mg daily; continue psychotherapy and CBT for insomnia; no new hypnotic",
          "One prescriber, a monitoring program check before every prescription, supplies of one to two weeks, locked storage, take-back of unused pills, and urine drug testing after the change to phenobarbital and periodically, explained as part of care",
          "Medroxyprogesterone or an intrauterine device for contraception, because phenobarbital weakens pills, patches, rings and implants",
          "Naloxone is not needed now; reassess if an opioid is ever prescribed",
          "Blood count and liver tests at three to four months on phenobarbital"
        ],
        "communication": "Discussed with Dr. Ellsworth-Diaz, who sees her the same day. The plan was explained to Ms. Garland, who agreed and chose the dates of the admission around her work",
        "follow_up": "Addiction medicine team during the admission; review by video at the end of the taper or sooner if withdrawal symptoms or a return to secobarbital or a stimulant occur; Dr. Ellsworth-Diaz continues prescribing"
      },
      "guideline_ids": [
        "GL-BZD-TAPER-2025",
        "GL-ASAM-AWM-2020",
        "GL-ASAM-STIM-2024",
        "GL-AASM-INSOMNIA-2017",
        "GL-CDC-MEC-2024",
        "GL-CDC-PDMP"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She wants to stop needing pills to sleep and to work, without being made to feel she is to blame for them",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to the documented pills given in adolescence.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She is afraid of being unable to sleep or perform during the change",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She worries about her weight if she stops the stimulant",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Change from secobarbital to phenobarbital under supervision without a withdrawal seizure or delirium",
        "status": "completed",
        "target_date": "2026-07-20",
        "outcome": "Four-day supervised admission; no seizure, delirium or severe withdrawal",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic withdrawal-safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Lower the phenobarbital dose slowly, at no more than about 20% every two weeks, toward stopping",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "97.2 mg a day at discharge to 32.4 mg a day at four months; two pauses when needed; taper continuing",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic taper goal; the end of the taper falls after the episode.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Stop dextroamphetamine with a short taper and no return to it",
        "status": "completed",
        "target_date": "2026-08-31",
        "outcome": "Stopped after a two-week taper; tiredness for about two weeks, then better",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic stimulant goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Sleep six hours or more on most nights using CBT for insomnia",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "About six hours on most nights; rebound wakefulness after each dose step settles within a week",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "PHQ-9 below 5 by six months",
        "status": "active",
        "target_date": "2026-10-26",
        "outcome": "PHQ-9 14 to 5 at four months; response",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Regular meals and weight she is comfortable with, without dieting drugs",
        "status": "completed",
        "target_date": "2026-10-26",
        "outcome": "Three meals on most days; weight up 3.5 kg to a BMI of 21.9; she says she feels stronger",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic nutrition goal set with her, without a weight-loss target.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Safe prescribing of controlled drugs: one prescriber and one pharmacy, a prescription drug monitoring program check before every controlled-substance prescription, a written shared treatment agreement, urine drug testing explained as part of care, seven-day supplies at first, a locked box, and take-back of unused capsules",
        "status": "completed",
        "guideline_ids": [
          "GL-BZD-TAPER-2025",
          "GL-CDC-PDMP"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic safe-prescribing plan, the teaching point of the case.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Addiction medicine consultation to confirm the diagnoses, plan a safe barbiturate withdrawal and taper, and advise on stopping the stimulant",
        "status": "completed",
        "guideline_ids": [
          "GL-BZD-TAPER-2025",
          "GL-ASAM-AWM-2020",
          "GL-ASAM-STIM-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Supervised barbiturate withdrawal: a short hospital admission to change secobarbital to phenobarbital with withdrawal scoring and seizure precautions, then a slow outpatient phenobarbital taper of no more than about 20% every two weeks, slower toward the end, paused for withdrawal symptoms, illness or a major performance, never stopped abruptly; no benzodiazepine or Z-drug in its place; no alcohol",
        "status": "completed",
        "guideline_ids": [
          "GL-BZD-TAPER-2025",
          "GL-ASAM-AWM-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic withdrawal plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-06-29"
      },
      {
        "id": "INT-004",
        "display": "Stimulant: dextroamphetamine held at one fixed morning dose until phenobarbital is stable, then 5 mg for two weeks and stopped, with mood, sleep and appetite checks; no other stimulant",
        "status": "completed",
        "guideline_ids": [
          "GL-ASAM-STIM-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic stimulant plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-06-29"
      },
      {
        "id": "INT-005",
        "display": "Insomnia: cognitive behavioral therapy for insomnia as first-line treatment, adapted to late performances (a fixed wake time, a wind-down routine after shows, sleep restriction only after the taper is stable), with a sleep diary; no new hypnotic",
        "status": "completed",
        "guideline_ids": [
          "GL-ACP-INSOMNIA-2016",
          "GL-AASM-INSOMNIA-2017"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic sleep plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Depression and anxiety: PHQ-9 and GAD-7 at each visit, sertraline, weekly psychotherapy, the Mood Disorder Questionnaire before the antidepressant, a structured safety assessment with a written safety plan, means safety and the 988 Suicide & Crisis Lifeline, and safety review at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-USPSTF-DEP-2023",
          "GL-SUICIDE-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood and safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Nutrition and weight without stigma: regular meals and snacks around rehearsals, a dietitian visit, no weight-loss target and no dieting drugs, and screening for disordered eating",
        "status": "completed",
        "guideline_ids": [
          "GL-ASAM-STIM-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic nutrition plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Contraception that barbiturates do not weaken: medroxyprogesterone injection every 13 weeks, after a negative pregnancy test, with an intrauterine device as an alternative",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-MEC-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic contraception plan for a woman taking an enzyme-inducing barbiturate three months after childbirth.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Naloxone not prescribed: she takes no opioid, has no opioid prescription in the monitoring program, her urine test shows no opioids or fentanyl, and all her pills come from a pharmacy; naloxone does not reverse a barbiturate overdose. To be offered at once if an opioid is ever prescribed or any pill comes from outside a pharmacy",
        "status": "completed",
        "guideline_ids": [
          "GL-ASAM-STIM-2024",
          "GL-CDC-PDMP"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic documented decision on naloxone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-010",
        "display": "Work: taper steps scheduled away from major performances, a written plan for late nights and travel, and letters she controls",
        "status": "completed",
        "guideline_ids": [
          "GL-BZD-TAPER-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic work plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-BZD-TAPER-2025",
        "title": "Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits",
        "publisher": "American Society of Addiction Medicine and nine partner organizations (J Gen Intern Med 2025;40(12):2814-2859)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40526204/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-ASAM-AWM-2020",
        "title": "The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management",
        "publisher": "American Society of Addiction Medicine (Journal of Addiction Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/32511109/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-ASAM-STIM-2024",
        "title": "The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder",
        "publisher": "American Society of Addiction Medicine and American Academy of Addiction Psychiatry (Journal of Addiction Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38669101/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-AASM-INSOMNIA-2017",
        "title": "Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline",
        "publisher": "American Academy of Sleep Medicine (Journal of Clinical Sleep Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27998379/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-ACP-INSOMNIA-2016",
        "title": "Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians",
        "publisher": "American College of Physicians (Annals of Internal Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/27136449/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-CDC-MEC-2024",
        "title": "U.S. Medical Eligibility Criteria for Contraceptive Use, 2024",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39106314/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CDC-PDMP",
        "title": "Prescription Drug Monitoring Programs (PDMPs)",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/overdose-prevention/hcp/clinical-guidance/prescription-drug-monitoring-programs.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "United States Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-TOB-2021",
        "title": "Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-IPV-2018",
        "title": "Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AAOHNS-DYSPHONIA-2018",
        "title": "Clinical Practice Guideline: Hoarseness (Dysphonia) (Update)",
        "publisher": "American Academy of Otolaryngology-Head and Neck Surgery Foundation (Otolaryngology-Head and Neck Surgery)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29494321/",
        "version_or_year": "2018"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the DSM-5-TR criteria count that excludes tolerance and withdrawal, the secobarbital to phenobarbital conversion and the admission, the taper pace (the 2025 benzodiazepine guideline applied by analogy, since it excludes barbiturates), the order of the stimulant taper, sertraline with phenobarbital, the contraception choice with an enzyme inducer, and the decision not to prescribe naloxone."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: Women in World History (Encyclopedia.com), TIME (1969 and 2019), PBS American Masters, Biography.com (two articles), History.com, Kirkus Reviews and Publishers Weekly reviews of Gerald Clarke's biography, and TV Guide (1955) through the Media History Digital Library. The biography itself was not read. Who first gave her pills is graded R and disputed."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Substance use and mental health claims are marked sensitive; past suicide attempts and hospital stays are recorded without detail; her death is recorded once in one plain sentence; person-first language; the pills given to her as a minor are presented as harm done to her, not her fault; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety. No living relative is named."
    }
  }
}
